Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Savile Finance’s two funds maintain positive performance

Monday, July 23, 2012

Precy Dumlao, Opalesque Asia: Two Savile Finance Group’s funds closed the month of June up with their Bermuda-based Savile Opportunity Fund International up +1.04% last month (+4.69% YTD), and the U.S.-based Savile Opportunity Fund up +1.12% over the same period (+4.62% YTD).

Since their inception in 2006 and 2007 the programs have always been positive on an annual basis, the company said in a statement. The Savile Opportunity Fund International and Savile Opportunity Fund are currently featured in Opalesque A SQUARE DB.

Background Savile makes direct loans to small and medium enterprises (SME’s) in the United States and select countries in Latin America, secured by inventory, receivables and other assets of the borrowers. Key to Savile’s approach is combining its broad origination network with a robust proprietary credit analysis, risk control and servicing platform.

SOF is a direct lending fund which predominantly invests in transactions secured and backed by liquid short-term assets. SFG’s investment strategy is at its core a credit arbitrage of taking the credit risk of a large account debtor while charging a higher rate to the small clients who have restricted acces......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its